Efecto del sulfato de magnesio intravenoso en la exacerbación de la EPOC que precisa hospitalización: estudio aleatorizado controlado con placebo

Intravenous administration of magnesium sulfate has no bronchodilating effect in patients with COPD exacerbations. It does, however, enhance the bronchodilating effect of inhaled β2-agonists.